483 Halo Pharmaceutical Mar 2002

483 Halo Pharmaceutical Mar 2002

Richard Thornton FDA$119.00 - Available Now

FDA investigators audited the Halo Pharmaceutical - Whippany, NJ, United States facility and issued inspectional observations (via FDA 483) on 06 Mar 2002.

Product details

  • Category: Biologics
  • Inspection end: 06 Mar 2002
  • Location: Whippany, United States
  • FEI: 2211084
Add To Cart